I am asking if you think the Rituxan agreement with BIIB will change if Roche takes over DNA
As far as I can tell, it will not. Roche’s acquiring the rest of DNA does not trigger a change of control provision in the Rituxan agreement between DNA and BIIB because Roche already has a majority ownership stake in DNA.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”